https://www.prnewswire.com/news-releases/taiho-oncology-announces-publication-in-the-new-england-journal-of-medicine-of-pivotal-data-for-futibatinib-in-previously-treated-patients-with-metastatic-intrahepatic-cholangiocarcinoma-301725166.html
0
0
Taiho Oncology Announces Publication in The New England Journal of Medicine of Pivotal Data for Futibatinib in Previously Treated Patients With Metastatic Intrahepatic Cholangiocarcinoma - PR Newswire
1/18/23 at 10:00pm
Organization
PRNewswire
Authors
Details
49 words
Summarize
Cancer Business & Industrial Taiho Oncology Announces Publication Intrahepatic The New England Journal of Medicine of Pivotal Data for Futibatinib PRNewswire futibatinib Phase 2 FOENIX
/PRNewswire/ -- Taiho Oncology, Inc. today announced the publication of results from the pivotal Phase 2 FOENIX*-CCA2 clinical trial of futibatinib in the...
Create an account or login to join the discussion